Japan Hosts $270 Million in COVID-Related Pharma Projects
Japan Hosts $270 Million in COVID-Related Pharma Projects
KOFU, JAPAN--September 8, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Industrial Info is tracking six capital Pharmaceutical-Biotech projects related to COVID-19, worth more than $270 million, in Japan. Projects include a grassroot vaccine fill and finish plant, and a Biosafety Level-4 laboratory.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Japan Hosts $550 Million in Fill-and-Finish Pharma Projects
- Japan Hosts $290 Million in COVID-Related Pharma Projects
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
